Pharmacist Care

OTHER3 trials

Sponsors

University of Alberta, Kaiser Permanente

Conditions

Attention-deficit HyperactivityCOVID-19DyslipidemiasQuality of Care

Unknown Phase

A Community Based Approach to Dyslipidemia Management: Pharmacist Prescribing to Achieve Cholesterol Targets

CompletedNCT01581372

University of AlbertaDyslipidemias

Start: 2011-12-31End: 2013-01-31Updated: 2015-04-28

Pharmacist Management of Paxlovid eVisits

CompletedNCT06076863

Kaiser PermanenteCOVID-19, Quality of Care

Start: 2023-10-09End: 2024-01-11Updated: 2024-03-04

Pharmacist Management of Attention Deficit Hyperactivity Disorder Medication Refill Requests

CompletedNCT06388694

Kaiser PermanenteAttention-deficit Hyperactivity

Start: 2024-05-06End: 2024-07-31Updated: 2024-08-30

Related Papers

Pharmacist care for attention-deficit/hyperactivity disorder electronic medication refills: A cluster randomized trial.

2025-11-01